Apraglutide
- Generic Name
- Apraglutide
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1295353-98-8
- Unique Ingredient Identifier
- CVQ1IAY2G6
- Associated Conditions
- -
- Associated Therapies
- -
Relative Bioavailability of a New Presentation of Apraglutide Versus the Reference Formulation
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- VectivBio AG
- Target Recruit Count
- 34
- Registration Number
- NCT06002555
- Locations
- 🇳🇱
ICON Clinical Research Unit, Groningen, Netherlands
Evaluation of Apraglutide on Gastric Emptying
- Conditions
- Interventions
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- VectivBio AG
- Target Recruit Count
- 42
- Registration Number
- NCT05995704
- Locations
- 🇳🇱
ICON Clinical Research Unit, Groningen, Netherlands
A Phase 1, Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Hepatic Function
- First Posted Date
- 2023-01-31
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- VectivBio AG
- Target Recruit Count
- 16
- Registration Number
- NCT05706623
- Locations
- 🇩🇪
APEX, Münich, Germany
🇸🇰Summit Clinical Research, Bratislava, Slovakia
Proof-of-concept Trial of Apraglutide in GVHD
- First Posted Date
- 2022-06-13
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- VectivBio AG
- Target Recruit Count
- 31
- Registration Number
- NCT05415410
- Locations
- 🇺🇸
The Ohio State University, Columbus, Ohio, United States
🇩🇪Universitätsmedizin der Johannes Gutenberg - Universität Mainz, Mainz, Germany
🇩🇪Universitaetsklinikum Duesseldorf, Düsseldorf, Germany
Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
- First Posted Date
- 2021-08-24
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- VectivBio AG
- Target Recruit Count
- 158
- Registration Number
- NCT05018286
- Locations
- 🇯🇵
Yokohama Municipal Citizen's Hospital, Kanagawa, Japan
🇺🇸Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
🇺🇸Gastroenterology Group of Naples, Naples, Florida, United States
Metabolic Balance Study of Apraglutide in Patients With SBS-IF and Colon-in-Continuity
- First Posted Date
- 2021-07-16
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- VectivBio AG
- Target Recruit Count
- 9
- Registration Number
- NCT04964986
- Locations
- 🇫🇷
Beaujon Hospital, Clichy, France
🇧🇪UZ Leuven, Leuven, Belgium
Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.
- First Posted Date
- 2021-01-07
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- VectivBio AG
- Target Recruit Count
- 16
- Registration Number
- NCT04699032
- Locations
- 🇺🇸
Prism Clinical Research, Inc., Saint Paul, Minnesota, United States
🇺🇸Orlando Clinical Research Center, Orlando, Florida, United States
Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF
- First Posted Date
- 2020-11-13
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- VectivBio AG
- Target Recruit Count
- 164
- Registration Number
- NCT04627025
- Locations
- ðŸ‡ðŸ‡º
University of Szeged, Szeged, Hungary
🇺🇸Duke University Hospital, Durham, North Carolina, United States
🇩🇰Rigshospitalet - University Hospital Copenhagen, Copenhagen, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.